# RYTHM, Inc.: overview

RYM · Nasdaq · CIK 1800637 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rym.md) · [Financials](/companies/rym/financials.md) · [Filings](/companies/rym/filings.md) · [Insiders](/companies/rym/insiders.md)

Latest reported revenue: [$23.0m](/filings/0001213900-26-084899.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-084899).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.9](/filings/0001213900-24-098443.md) | [(7.5) d](/filings/0001213900-26-023069.md) | [0.5](/filings/0001213900-26-052195.md) | [2.0](/filings/0001213900-26-084899.md) | [4.0](/filings/0001213900-25-107368.md) | [10.7 d](/filings/0001213900-26-023069.md) | [13.3](/filings/0001213900-26-052195.md) | [23.0](/filings/0001213900-26-084899.md) |
| Gross margin | % | [11.6%](/filings/0001213900-24-098443.md) | [21.2% d](/filings/0001213900-26-023069.md) | [16.7%](/filings/0001213900-26-052195.md) | [33.4%](/filings/0001213900-26-084899.md) | [34.0%](/filings/0001213900-25-107368.md) | [75.5% d](/filings/0001213900-26-023069.md) | [78.3%](/filings/0001213900-26-052195.md) | [80.5%](/filings/0001213900-26-084899.md) |
| Operating margin | % | [(63.1%)](/filings/0001213900-25-107368.md) | [46.1% d](/filings/0001213900-26-023069.md) | [(687.9%)](/filings/0001213900-26-052195.md) | [(332.9%)](/filings/0001213900-26-084899.md) | [(219.8%)](/filings/0001213900-25-107368.md) | [(121.5%) d](/filings/0001213900-26-023069.md) | [(30.4%)](/filings/0001213900-26-052195.md) | [8.4%](/filings/0001213900-26-084899.md) |
| Net margin | % | [(964.4%)](/filings/0001213900-25-107368.md) | [324.4% d](/filings/0001213900-26-023069.md) | [(302.2%)](/filings/0001213900-26-084899.md) | [(360.4%)](/filings/0001213900-26-084899.md) | [(263.8%)](/filings/0001213900-25-107368.md) | [(127.6%) d](/filings/0001213900-26-023069.md) | [149.9%](/filings/0001213900-26-084899.md) | [5.1%](/filings/0001213900-26-084899.md) |
| Diluted EPS | $ per share | [(17.28)](/filings/0001213900-25-107368.md) | not reported | [(0.83)](/filings/0001213900-26-052195.md) | [(3.74)](/filings/0001213900-26-084899.md) | [(5.33)](/filings/0001213900-25-107368.md) | not reported | [1.33](/filings/0001213900-26-052195.md) | [0.09](/filings/0001213900-26-084899.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [59.9](/filings/0001213900-23-090353.md) | [58.3](/filings/0001213900-24-033048.md) | [15.1](/filings/0001013762-25-003503.md) | [0.0](/filings/0001213900-26-023069.md) | [17.3](/filings/0001213900-26-023069.md) |
| Gross margin | % | [8.7%](/filings/0001213900-23-090353.md) | [(54.6%)](/filings/0001213900-24-033048.md) | [26.5%](/filings/0001013762-25-003503.md) | [(394.4%)](/filings/0001213900-26-023069.md) | [59.0%](/filings/0001213900-26-023069.md) |
| Operating margin | % | [(58.6%)](/filings/0001213900-23-090353.md) | [(331.8%)](/filings/0001213900-24-033048.md) | [(86.0%)](/filings/0001013762-25-003503.md) | [(28183.3%)](/filings/0001213900-26-023069.md) | [(187.1%)](/filings/0001213900-26-023069.md) |
| Net margin | % | [(54.2%)](/filings/0001213900-23-090353.md) | [(323.0%)](/filings/0001213900-24-033048.md) | [(123.2%)](/filings/0001013762-25-003503.md) | [(231922.2%)](/filings/0001213900-26-023069.md) | [(192.4%)](/filings/0001213900-26-023069.md) |
| Diluted EPS | $ per share | [(1.69)](/filings/0001213900-22-016936.md) | [(902.19)](/filings/0001213900-24-033048.md) | [(187.64)](/filings/0001013762-25-003503.md) | [(40.92)](/filings/0001213900-26-023069.md) | [(16.68)](/filings/0001213900-26-023069.md) |
| Free cash flow | $m | [(32.4)](/filings/0001213900-23-090353.md) | [(80.2)](/filings/0001213900-24-033048.md) | [(31.0)](/filings/0001013762-25-003503.md) | [(11.6)](/filings/0001213900-26-023069.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rym/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.2m | 45,191 |  | Added +17,822 |
| [IEQ CAPITAL, LLC](/funds/1779789.md) | 2026-06-30 | $889.2k | 34,897 |  | Unchanged |
| [Concurrent Investment Advisors, LLC](/funds/2001015.md) | 2026-06-30 | $563.1k | 22,100 |  | Added +10,779 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $349.3k | 13,706 |  | Unchanged |
| [Tidal Investments LLC](/funds/1600064.md) | 2026-06-30 | $314.8k | 12,356 |  | Reduced −1,953 |
| [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $242.1k | 9,500 |  | New +9,500 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $214.4k | 8,416 |  | New +8,416 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $193.5k | 7,593 |  | Added +51 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $121.3k | 4,759 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $107.0k | 4,199 |  | Added +4,127 |

## Recent filings

[All 442 filings](/companies/rym/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 11:00 ET | [8-K](/filings/0001213900-26-110006.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-110006 |
| 2026-09-03 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001213900-26-097252.md) | Ownership report, active investor, amended | 0001213900-26-097252 |
| 2026-08-11 | 00:00 ET | [SCHEDULE 13D/A](/filings/0001213900-26-087926.md) | Ownership report, active investor, amended | 0001213900-26-087926 |
| 2026-08-11 | 11:00 ET | [8-K](/filings/0001213900-26-087480.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-087480 |
| 2026-08-04 | 11:10 ET | [10-Q](/filings/0001213900-26-084899.md) | Quarterly report, period 2026-06-30 | 0001213900-26-084899 |
| 2026-08-04 | 11:05 ET | [8-K](/filings/0001213900-26-084896.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-084896 |
| 2026-07-09 | 13:13 ET | [DEF 14A](/filings/0001213900-26-076533.md) | Proxy statement, period 2026-08-10 | 0001213900-26-076533 |
| 2026-06-18 | 11:00 ET | [8-K](/filings/0001213900-26-069851.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-069851 |
| 2026-05-05 | 20:11 ET | [10-Q](/filings/0001213900-26-052195.md) | Quarterly report, period 2026-03-31 | 0001213900-26-052195 |
| 2026-05-05 | 20:06 ET | [8-K](/filings/0001213900-26-052186.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-052186 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-023069.md), filed Mar 3, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7b5b09e0-73d2-40f7-b9f7-ab5ab336d789)

## About the filer

- CIK: 1800637
- Tickers: RYM
- Exchange: Nasdaq
- SIC code: 700 Agricultural Services
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.